Related Experiment Video
Updated: May 22, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Ethical challenges in paediatric clinical trials in multiple sclerosis
1Staff Neurologist, Department of Neurology, National Pediatric Hospital Dr Juan P. Garrahan, Billinghurst 850. Buenos Aires, 1174 Argentina.
Therapeutic Advances in Neurological Disorders
|May 17, 2012
Summary
Pediatric multiple sclerosis (MS) treatments show limited efficacy and inconvenient administration. Emerging therapies offer oral options but require careful trial design due to safety and feasibility concerns in children.
Area of Science:
- Pediatric neurology
- Neuroimmunology
- Clinical pharmacology
Background:
- Children and adolescents with multiple sclerosis (MS) experience high relapse rates and cognitive decline.
- Current standard treatments (interferon-beta, glatiramer acetate) are adapted from adult protocols, showing some safety and efficacy but with administration challenges.
Purpose of the Study:
- To review the current landscape of multiple sclerosis (MS) treatments in pediatric patients.
- To discuss the potential and challenges of emerging therapies for pediatric MS.
- To highlight considerations for future clinical trials in this population.
Main Methods:
- Review of existing literature on pediatric multiple sclerosis (MS) treatment.
- Analysis of safety, efficacy, and administration routes of current and emerging immunomodulatory therapies.
- Discussion of ethical and feasibility issues in pediatric clinical trial design.
Main Results:
- Established therapies are safe and well-tolerated but offer only partial efficacy and inconvenient administration.
- Emerging therapies, including oral options, show promise for improved disease control.
- Significant challenges exist for pediatric clinical trials, including ethical considerations, feasibility, and small patient populations.
Conclusions:
- New therapies are needed to optimize care for pediatric MS patients.
- Future trials must be multicenter, define key outcomes, and carefully weigh risks and benefits.
- Careful consideration of pediatric-specific factors is crucial for advancing treatment options.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:17Ethical Dilemmas I
Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...